PD-1 and CTLA-4 as biomarkers for survival in kidney cancer

A recent study published in Journal of Clinical Medicine last month provides evidence for the expression of PD-1 and CTLA-4 receptors on white blood cells (tumour-infiltrating mononuclear cells) to be associated with a worse overall survival in patient with renal cell carcinoma (RCC).

The combination of PD-1 and CTLA-4 expression in tumour-infiltrating mononuclear cells might identify patients at high risk.

Read more in UroToday here

 

Share this Post!


Related post

  TOP